Oral cavity and oropharynx cancer: Difference between revisions
(Created page with "'''Oral cavity cancer''' or (simply '''oral cancer''') and '''oropharynx cancer''' are forms of head and neck cancer. These have similar etiology and pathology and are therefore often considered together. Squamous cell carcinoma is the most common histological type of oral cavity and oropharynx cancer. Oropharynx cancer is most commonly located in the tonsils and tongue base but may affect all parts of the oropharynx. == Etiology == These types of cancer are highly...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Oral cavity cancer''' or (simply '''oral cancer''') and '''oropharynx cancer''' are forms of [[head and neck cancer]]. These have similar etiology and pathology and are therefore often considered together. Squamous cell carcinoma is the most common histological type of oral cavity and oropharynx cancer. Oropharynx cancer is most commonly located in the tonsils and tongue base but may affect all parts of the oropharynx. | <section begin="oncology" />'''Oral cavity cancer''' or (simply '''oral cancer''') and '''oropharynx cancer''' are forms of [[head and neck cancer]]. These have similar etiology and pathology and are therefore often considered together. Squamous cell carcinoma is the most common histological type of oral cavity and oropharynx cancer. Oropharynx cancer is most commonly located in the tonsils and tongue base but may affect all parts of the oropharynx. | ||
== Etiology == | == Etiology == | ||
| Line 13: | Line 13: | ||
== Management == | == Management == | ||
Management includes surgical removal, sometimes with adjuvant radiotherapy. | |||
<noinclude>[[Category:Ear, nose, throat (ENT)]]</noinclude> | === Oral cavity cancer === | ||
Management includes surgical removal, sometimes with adjuvant radiotherapy. Postoperative radiotherapy or radiochemotherapy is indicated if high-risk features are present | |||
* R1 or R2 resection | |||
* T3 or T4 tumours | |||
* Lymph node spread | |||
Before radiotherapy of the oral cavity, dental care is essential. Dental infections can act as a source of inflammation after radiotherapy. | |||
=== Oropharyngeal cancer === | |||
Oropharyngeal cancer is moderately radiosensitive. For this reason, radiochemotherapy is the preferred modality, but surgery is an option. | |||
<section end="oncology" /><noinclude> | |||
[[Category:Ear, nose, throat (ENT)]][[Category:Oncology]] | |||
</noinclude> | |||
Latest revision as of 13:46, 28 July 2024
Oral cavity cancer or (simply oral cancer) and oropharynx cancer are forms of head and neck cancer. These have similar etiology and pathology and are therefore often considered together. Squamous cell carcinoma is the most common histological type of oral cavity and oropharynx cancer. Oropharynx cancer is most commonly located in the tonsils and tongue base but may affect all parts of the oropharynx.
Etiology
These types of cancer are highly related to tobacco use, smoking, alcohol, and HPV. The combined use of tobacco and alcohol has a multiplicative effect on cancer risk.
Leukoplakia is a precursor to oral cavity cancer.
Clinical features
Oral cavity cancer most commonly presents as a non-healing ulcer or lesion. Oropharyngeal cancer is usually asymptomatic early, leading to late diagnosis. Later, it may cause sore throat, globus sensation, bloody saliva, halitosis, and pain. Lymph node metastasis may cause swollen lymph nodes on the neck, especially the mandibular angle.
Diagnosis and evaluation
Ultrasound is useful in the evaluation of oropharynx cancer, not usually necessary for oral cavity cancer. Biopsy is essential for the diagnosis.
Management
Oral cavity cancer
Management includes surgical removal, sometimes with adjuvant radiotherapy. Postoperative radiotherapy or radiochemotherapy is indicated if high-risk features are present
- R1 or R2 resection
- T3 or T4 tumours
- Lymph node spread
Before radiotherapy of the oral cavity, dental care is essential. Dental infections can act as a source of inflammation after radiotherapy.
Oropharyngeal cancer
Oropharyngeal cancer is moderately radiosensitive. For this reason, radiochemotherapy is the preferred modality, but surgery is an option.